Aveanna Healthcare Refinances $1.3B Debt, Cuts Interest Margins by 50 Bps
AVAH sits 97% above its 52-week low of $3.73.
Summary
Aveanna Healthcare completed a significant $1.318 billion term loan refinancing, which follows an 8-K filed earlier today detailing the same event. This move reduces the company's interest rate margins by 50 basis points, immediately lowering borrowing costs on a substantial portion of its debt. The refinancing also includes a new $250 million revolving credit facility, maintaining liquidity. This reduction in interest expense will positively impact the company's profitability and cash flow. An additional 25 basis point margin reduction is available if the company achieves a higher credit rating.
At the time of this announcement, AVAH was trading at $7.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $3.73 to $10.32. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.